ELVN:NASDAQ
Enliven Therapeutics Inc
US$46,21
arrow_upward
+0,81%(+0,37) 1D
US$46,21
0,00% (0,00)
bedtimeAfter hours
Closed: 1 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ELVN...
Open
US$46,29
High
US$47,22
Low
US$45,70
Mkt. cap
3,39 ຕື້
Avg. vol.
1,28 ລ້ານ
Volume
944,89 ພັນ
52-wk high
US$62,32
52-wk low
US$14,78
EPS
US$-1,67
Beta
0,30
Shares outstanding
73,27 ລ້ານ
No. of employees
67
Open
US$46,29
High
US$47,22
Low
US$45,70
Mkt. cap
3,39 ຕື້
Avg. vol.
1,28 ລ້ານ
Volume
944,89 ພັນ
52-wk high
US$62,32
52-wk low
US$14,78
EPS
US$-1,67
Beta
0,30
Shares outstanding
73,27 ລ້ານ
No. of employees
67
News stories
From web sources and news partners
Stock Titan
·
4 ຊົ່ວໂມງກ່ອນ
Director Jeffrey Garland proposes selling 13,000 Enliven Therapeutics (NASDAQ: ELVN) shares.
Investing.com
·
16 ຊົ່ວໂມງກ່ອນ
Enliven Therapeutics stock initiated at Overweight by JPMorgan
Stock Traders Daily
·
16 ຊົ່ວໂມງກ່ອນ
Understanding the Setup: (ELVN) and Scalable Risk
About Enliven Therapeutics Inc
CEO-
Employees67
Founded2016
Headquartersເບົາເດີ, ໂຄໂລຣາໂດ, ສະຫະລັດ
SectorPharmaceutical industry
Websiteimaratx.com